Relationship of potency and resilience to drug resistant mutations for GW420867X revealed by crystal structures of inhibitor complexes for wild-type, Leu100Ile, Lys101Glu, and Tyr188Cys mutant HIV-1 reverse transcriptases.

The selection of drug resistant viruses is a major problem in efforts to combat HIV and AIDS, hence, new compounds are required. We report crystal structures of wild-type and mutant HIV-1 RT with bound non-nucleoside (NNRTI) GW420867X, aimed at investigating the basis for its high potency and improv...

Full description

Bibliographic Details
Main Authors: Ren, J, Nichols, C, Chamberlain, P, Weaver, K, Short, SA, Chan, J, Kleim, J, Stammers, D
Format: Journal article
Language:English
Published: 2007
_version_ 1797075092200488960
author Ren, J
Nichols, C
Chamberlain, P
Weaver, K
Short, SA
Chan, J
Kleim, J
Stammers, D
author_facet Ren, J
Nichols, C
Chamberlain, P
Weaver, K
Short, SA
Chan, J
Kleim, J
Stammers, D
author_sort Ren, J
collection OXFORD
description The selection of drug resistant viruses is a major problem in efforts to combat HIV and AIDS, hence, new compounds are required. We report crystal structures of wild-type and mutant HIV-1 RT with bound non-nucleoside (NNRTI) GW420867X, aimed at investigating the basis for its high potency and improved drug resistance profile compared to the first-generation drug nevirapine. GW420867X occupies a smaller volume than many NNRTIs, yet accesses key regions of the binding pocket. GW420867X has few contacts with Tyr188, hence, explaining the small effect of mutating this residue on inhibitor-binding potency. In a mutated NNRTI pocket, GW420867X either remains in a similar position compared to wild-type (RT(Leu100Ile) and RT(Tyr188Cys)) or rearranges within the pocket (RT(Lys101Glu)). For RT(Leu100Ile), GW420867X does not shift position, in spite of forming different side-chain contacts. The small bulk of GW420867X allows adaptation to a mutated NNRTI binding site by repositioning or readjustment of side-chain contacts with only small reductions in binding affinity.
first_indexed 2024-03-06T23:45:24Z
format Journal article
id oxford-uuid:70bb55e3-7761-45dd-9957-1c918033fb62
institution University of Oxford
language English
last_indexed 2024-03-06T23:45:24Z
publishDate 2007
record_format dspace
spelling oxford-uuid:70bb55e3-7761-45dd-9957-1c918033fb622022-03-26T19:39:05ZRelationship of potency and resilience to drug resistant mutations for GW420867X revealed by crystal structures of inhibitor complexes for wild-type, Leu100Ile, Lys101Glu, and Tyr188Cys mutant HIV-1 reverse transcriptases.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:70bb55e3-7761-45dd-9957-1c918033fb62EnglishSymplectic Elements at Oxford2007Ren, JNichols, CChamberlain, PWeaver, KShort, SAChan, JKleim, JStammers, DThe selection of drug resistant viruses is a major problem in efforts to combat HIV and AIDS, hence, new compounds are required. We report crystal structures of wild-type and mutant HIV-1 RT with bound non-nucleoside (NNRTI) GW420867X, aimed at investigating the basis for its high potency and improved drug resistance profile compared to the first-generation drug nevirapine. GW420867X occupies a smaller volume than many NNRTIs, yet accesses key regions of the binding pocket. GW420867X has few contacts with Tyr188, hence, explaining the small effect of mutating this residue on inhibitor-binding potency. In a mutated NNRTI pocket, GW420867X either remains in a similar position compared to wild-type (RT(Leu100Ile) and RT(Tyr188Cys)) or rearranges within the pocket (RT(Lys101Glu)). For RT(Leu100Ile), GW420867X does not shift position, in spite of forming different side-chain contacts. The small bulk of GW420867X allows adaptation to a mutated NNRTI binding site by repositioning or readjustment of side-chain contacts with only small reductions in binding affinity.
spellingShingle Ren, J
Nichols, C
Chamberlain, P
Weaver, K
Short, SA
Chan, J
Kleim, J
Stammers, D
Relationship of potency and resilience to drug resistant mutations for GW420867X revealed by crystal structures of inhibitor complexes for wild-type, Leu100Ile, Lys101Glu, and Tyr188Cys mutant HIV-1 reverse transcriptases.
title Relationship of potency and resilience to drug resistant mutations for GW420867X revealed by crystal structures of inhibitor complexes for wild-type, Leu100Ile, Lys101Glu, and Tyr188Cys mutant HIV-1 reverse transcriptases.
title_full Relationship of potency and resilience to drug resistant mutations for GW420867X revealed by crystal structures of inhibitor complexes for wild-type, Leu100Ile, Lys101Glu, and Tyr188Cys mutant HIV-1 reverse transcriptases.
title_fullStr Relationship of potency and resilience to drug resistant mutations for GW420867X revealed by crystal structures of inhibitor complexes for wild-type, Leu100Ile, Lys101Glu, and Tyr188Cys mutant HIV-1 reverse transcriptases.
title_full_unstemmed Relationship of potency and resilience to drug resistant mutations for GW420867X revealed by crystal structures of inhibitor complexes for wild-type, Leu100Ile, Lys101Glu, and Tyr188Cys mutant HIV-1 reverse transcriptases.
title_short Relationship of potency and resilience to drug resistant mutations for GW420867X revealed by crystal structures of inhibitor complexes for wild-type, Leu100Ile, Lys101Glu, and Tyr188Cys mutant HIV-1 reverse transcriptases.
title_sort relationship of potency and resilience to drug resistant mutations for gw420867x revealed by crystal structures of inhibitor complexes for wild type leu100ile lys101glu and tyr188cys mutant hiv 1 reverse transcriptases
work_keys_str_mv AT renj relationshipofpotencyandresiliencetodrugresistantmutationsforgw420867xrevealedbycrystalstructuresofinhibitorcomplexesforwildtypeleu100ilelys101gluandtyr188cysmutanthiv1reversetranscriptases
AT nicholsc relationshipofpotencyandresiliencetodrugresistantmutationsforgw420867xrevealedbycrystalstructuresofinhibitorcomplexesforwildtypeleu100ilelys101gluandtyr188cysmutanthiv1reversetranscriptases
AT chamberlainp relationshipofpotencyandresiliencetodrugresistantmutationsforgw420867xrevealedbycrystalstructuresofinhibitorcomplexesforwildtypeleu100ilelys101gluandtyr188cysmutanthiv1reversetranscriptases
AT weaverk relationshipofpotencyandresiliencetodrugresistantmutationsforgw420867xrevealedbycrystalstructuresofinhibitorcomplexesforwildtypeleu100ilelys101gluandtyr188cysmutanthiv1reversetranscriptases
AT shortsa relationshipofpotencyandresiliencetodrugresistantmutationsforgw420867xrevealedbycrystalstructuresofinhibitorcomplexesforwildtypeleu100ilelys101gluandtyr188cysmutanthiv1reversetranscriptases
AT chanj relationshipofpotencyandresiliencetodrugresistantmutationsforgw420867xrevealedbycrystalstructuresofinhibitorcomplexesforwildtypeleu100ilelys101gluandtyr188cysmutanthiv1reversetranscriptases
AT kleimj relationshipofpotencyandresiliencetodrugresistantmutationsforgw420867xrevealedbycrystalstructuresofinhibitorcomplexesforwildtypeleu100ilelys101gluandtyr188cysmutanthiv1reversetranscriptases
AT stammersd relationshipofpotencyandresiliencetodrugresistantmutationsforgw420867xrevealedbycrystalstructuresofinhibitorcomplexesforwildtypeleu100ilelys101gluandtyr188cysmutanthiv1reversetranscriptases